Rob Rutherford is a geologist with over 30 years Australian and international exploration experience and has been involved in generative, feasibility and management roles in the copper, gold and base ...

由此可见，2025年内，在地缘政治风险更加可控的情况下，药明生物RDM业务增长的确定性也在增强，由此不难预判2025年的加速增长趋势。 D端持续领跑，R和M成未来增长新引擎 细分三大板块来看，药明生物的D端表现持续强势。2024年内，企业新增148个新开发（D ...

A founder of Turkish fast-delivery company Getir announced on Wednesday he would pursue legal action against what he called an "illegal coup" by Mubadala, the firm's largest shareholder, which was ...

KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec LLC, a subsidiary of Julphar. This acquisition strengthens ...

UAE - Kelix bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar. This acquisition strengthens ...

Getir’s founding team had previously clashed with investors, primarily Mubadala, over the company’s strategy and costs. Its valuation plunged to $2.5 billion in 2023 from its peak of $11.8 ...

A strategic move that further supports Mubadala’s efforts to advance the UAE's life sciences sector Following the acquisition of four GlobalOne Healthcare Holding assets, this transaction represents ...

Kelix bio, an emerging markets-focused specialty generic biopharmaceutical company has struck its fifth strategic deal since its acquisition by Abu Dhabi sovereign investor Mubadala Investment Company ...

Dubai-headquartered Kelix Bio, wholly owned by Abu Dhabi’s Mubadala Investment (Mubadala), has completed the acquisition of insulin manufacturer DiabTec, a subsidiary of Ras Al Khaimah-headquartered ...

Getir founders allege Mubadala breached restructuring agreement Mubadala claims founders failed to complete June agreement Mubadala says it will present new plan to Getir shareholders in coming ...